Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence

Accession: GSE238264
Source / host: GEO — NCBI GEO FTP
Disease relevance: MASLD / NAFLD / NASH (category: Transcriptomic, subtype: spatial transcriptomics)
Modality / assay: spatial
Platform: Other, GPL24676
Organism: human
Samples: 7
Size (indexed): 594.7 MB (623586248 bytes)
Downloaded bytes: 297.4 MB (311798291 bytes)
Access / raw: public / OPEN-raw

Download

Files

FileSizeSHA256
GSE238264_RAW.tar297.4 MBcb64aad38f3f9d94…
filelist.txt531 Bd6f150eab85f05f8…

Index note: 8 suppl file(s); GSE238264_RAW.tar

Crawled by masld-atlas-crawler v1.0 at 2026-08-02T19:22:25Z.

About this dataset

This Other, GPL24676 dataset provides single-cell gene expression from human liver samples, with disease state recorded as MASLD/NAFLD/NASH. It profiles about 7 cells or nuclei.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.